Based in the United Kingdom, Digistain is a startup.
Digistain develops a clinical diagnostic technology that uses infrared spectroscopy to analyze tissue chemistry for pathology, enabling objective assessment of cancer tissue and prediction of treatment response. Their solutions are intended for use by hospitals and pathology laboratories to support cancer diagnosis and therapy decision-making.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.